Phase 1b Study of Dulanermin (recombinant human Apo2L/TRAIL) in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Patients With Advanced Non-Squamous Non–Small-Cell Lung Cancer Although all ...
Clinical significance of selected angiogenesis and lymphangiogenesis modulators and markers in ovarian cancer patients. Tolerability of long-term use of trabectedin (Tr) in combination with pegylated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback